Curcumin mediates oxidative stress to play an anti-fibrotic role, focusing on liver, renal, myocardial and pulmonary fibrosis
This comprehensive review elucidates curcumin's antifibrotic potential and explores its translational applications in developing novel therapeutic strategies to combat fibrotic pathologies, supported by mechanistic evidence that informs safer, more effective treatment paradigms.
Authors
- Xiuli Yang (ORCID: https://orcid.org/0000-0001-6111-9927)
- Feifei Yang (ORCID: https://orcid.org/0000-0001-9362-7635)
- Yujiao He
- Jun Jiang (ORCID: https://orcid.org/0000-0002-5971-3174)
- Chuantao Zhang (ORCID: https://orcid.org/0000-0003-3726-7748)
- Ke Liu (ORCID: https://orcid.org/0000-0003-1450-910X)
- Xiao Liu (ORCID: https://orcid.org/0000-0002-8073-0534)
- Ke Chen (ORCID: https://orcid.org/0000-0003-2538-7793)
- Yi Zhu (ORCID: https://orcid.org/0000-0002-7673-7709)
- Cuifang He
- Maocai Luo (ORCID: https://orcid.org/0000-0002-5624-9572)
- Shishuang Yu
- Jufang Pu
Institutions
- Chengdu University (CN)
- Chengdu Fifth People's Hospital (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.3389/fphar.2025.1636538
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Natural Science Foundation of China
- Chengdu University of Traditional Chinese Medicine
- Chengdu University